Related Experiment Video
Updated: May 6, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Clinical course after surgical treatment of active isolated native mitral valve endocarditis
M Wilbring1, K Alexiou, M Tuan Nguyen
1Department of Cardiac Surgery, University Heart Center, Dresden, Germany - manuel.wilbring@gmail.com.
Aim:
Isolated mitral valve endocarditis (MVE) forms a particular subgroup within native infective valve endocarditis (NVE). We characterized this particular subgroup and analyzed the course of patients undergoing cardiac surgery.
Methods:
Between 1997 and 2011, 474 patients underwent cardiac surgery at our institution for NVE treatment. Of these, 89 patients (18.8%) suffered from MVE. Valve replacement was undertaken in 84.2% and valve repair in 15.8%. Follow-up was completed with 267 patient years.
Results:
A delay between the onset of first symptoms and surgery of 4.7±1.2 weeks was observed. Hence, most patients were in a critical preoperative state characterized by severe sepsis and destruction of the mitral valve. About 19.4% were emergency procedures. The MVE group presented with a higher prevalence of preoperative stroke, atrial fibrillation, coronary artery disease and chronic obstructive pulmonary disease in comparison with remaining NVE cases. MVE was more likely caused by Staphylococcus aureus; Staphylococcus epidermidis and Staphylococcus viridans were less frequent (P<0.01 each). Early mortality (6.7%) was caused by persistent sepsis. ICU stay >7 days and time on artificial ventilation >40 h led to a higher risk of in-hospital death. Five-year survival was 59.6% and affected by extracardiac comorbidities.
Conclusion:
Isolated MVE was characterized by a long delay before surgery, differences in microbiological findings and a higher prevalence of preoperative strokes in comparison to NVE. Surgery for MVE can be conducted with good clinical results, but mid-term outcome is limited by extracardiac comorbidities.
Insights
Isolated mitral valve endocarditis (MVE) patients often face surgical delays and present with severe sepsis. Cardiac surgery offers good results, but long-term survival depends on managing extracardiac conditions.
Area of Science:
- Cardiology
- Infectious Diseases
- Cardiac Surgery
Background:
- Isolated mitral valve endocarditis (MVE) is a distinct subgroup of native infective valve endocarditis (NVE).
- Characterizing MVE and analyzing surgical outcomes is crucial for improving patient management.
Purpose of the Study:
- To characterize isolated mitral valve endocarditis (MVE).
- To analyze the clinical course and outcomes of patients with MVE undergoing cardiac surgery.
Main Methods:
- Retrospective analysis of 474 patients with NVE from 1997-2011.
- Identified 89 patients (18.8%) with MVE, analyzing demographics, comorbidities, surgical procedures, and outcomes.
- Follow-up data comprised 267 patient-years.
Main Results:
- A significant delay (4.7±1.2 weeks) between symptom onset and surgery was observed, with many patients critically ill.
- MVE patients had higher rates of stroke, atrial fibrillation, CAD, and COPD; Staphylococcus aureus was the predominant pathogen.
- Early mortality (6.7%) was linked to sepsis; prolonged ICU stay and ventilation increased in-hospital death risk. Five-year survival was 59.6%, impacted by extracardiac comorbidities.
Conclusions:
- Isolated MVE presents unique challenges including delayed diagnosis, specific microbiological profiles, and increased stroke prevalence.
- Cardiac surgery for MVE can achieve favorable clinical results.
- Mid-term survival is significantly influenced by the presence of extracardiac comorbidities.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis

